SMFM 2025 Pregnancy Meeting Postgraduate Courses, Presentations & Poster Sessions
Monday, January 27th
Postgraduate Course 11:05 AM (Summit 6-7, Lobby Level):
- “To Scope or Not to Scope: Considering Prenatal Closure of MMC When do I refer the patient?”An MFM’s Guide to Fetal Interventions – presented jointly with the North American Fetal Therapy Network (NAFTNet)
Presenter: Ramesha Papanna, MD, MPH
Wednesday, January 29th
Postgraduate Course 8:00 AM – 12:00 PM Aurora Ballroom C, Lobby Level:
- Innovation and Challenges in Diagnosis and Management of HTN Complications
Presenters: Michal Fishel Bartal, MD & Baha Sibai, MD
Postgraduate Course 8:00 AM – 8:15 AM Aurora Ballroom C, Lobby Level:
- Targeted Therapy For Prevention and Treatment of Preeclampsia
Presenters: Michal Fishel Bartal, MD & Baha Sibai, MD
Postgraduate Course 8:15 – 9:00 AM Aurora Ballroom C, Lobby Level:
- Controlling BP In Pregnancy: How Low Can You Go? – Chronic Hypertension GHTN/Preeclampsia
Presenter: Baha Sibai, MD
Postgraduate Course 9:30 – 10:00 AM Aurora Ballroom C, Lobby Level:
- Aspirin for Preeclampsia Prevention
Presenter: Farah H. Amro, MD
Postgraduate Course 10:30 – 11:15 AM Aurora Ballroom C, Lobby Level:
- Targeted Therapy For Prevention and Treatment of Preeclampsia
Presenter: Baha Sibai, MD
Postgraduate Course 11:15 – 11:45 AM Aurora Ballroom C, Lobby Level:
- Biomarkers for Preeclampsia Prediction vs. Clinical Utility
Presenter: Sean C. Blackwell, MD
Scientific Forums 3:30 – 4:00 PM Red Rock 10 – 11, Upper Level:
- Customization and Interpretation of CGM Reports
Presenter: Michal Fishel Bartal, MD
Scientific Forums 3:45 – 3:55 PM Red Rock 2-3 Upper Level:
- The ChorioAnchor
Presenter: Jimmy Espinoza MD, MSc
Scientific Forums 3:50 – 4:05 PM Red Rock 8, Upper Level:
- Paired Maternal-Child Care in Postpartum Period
Presenter: Farah Amro, MD
Scientific Forums 4:25 – 4:55 PM Summit 8 – 9, Lobby Level:
- Challenging Case Discussions: During this segment chairs will present two challenging and unique case presentation to start an open discussion about diagnosis and management between the audience, speakers, and chairs.
Panelist: Baha Sibai, MD
Thursday, January 30th
Oral Plenary Session 8:15 – 8:30 AM Aurora Ballroom, Lobby Level:
- The Frequency and Severity of Complications after Previable PROM in Texas following
Coauthors: Ghafir, Fahl, Ukoh, Chen, Blackwell, Gutierrez, Stafford
Oral Concurrent Session 1:30 – 1:45 PM Aurora Ballroom B, Lobby Level:
- Aberrant Fetal Growth in ARRIVE Trial
Submitting Author and Presenting Author: Bonnie L. Hermann, MD
Coauthor: Hector M. Mendez-Figueroa, MD
Oral Concurrent Session 2:00 – 2:15 PM Aurora Ballroom B, Lobby Level:
- Proportion of Time Spent in Category II Fetal Heart Tracing During Labor: Associated Adverse Outcomes
Submitting Author and Presenting Author: Kristen A. Cagino, MD
Coauthors: Roberts, Ibarra, Neff, Balhotra, Chahine, Cortes, Patel, Ghorayeb, Flores, Mendez-Figueroa,
Friday, January 31st
Oral Plenary Session 9:45 – 10:00 AM Aurora Ballroom, Lobby Level:
- Continuous Glucose Monitoring for Gestational Diabetes Diagnosis: A Comparative Effectiveness Randomized Control Trial (PRECISE)
Submitting Author and Presenting Author: Sarah A. Nazeer, MD
Coauthors: Cornthwaite, Santos, Pedroza, Blackwell, Amro, Bitar, Tyson, Sibai, Bartal
Oral Concurrent Session 1:30 – 1:45 PM Aurora Ballroom A, Lobby Level:
- Novel Neural Extracellular Vesicle miRNA Biomarkers Identify Suboptimal Response to Cooling in Neonatal Encephalopathy
Submitting Author and Presenting Author: Sarah T. Mehl, MD
Coauthors: Fekry, Ugartemendia, Goetzl
Oral Concurrent Session 2:15 – 2:30 PM Aurora Ballroom B, Lobby Level:
- Severe Systolic Hypertension and Adverse Maternal Outcomes
Submitting Author and Presenting Author: Yossi Bart, MD
Coauthors: Mendez-Figueroa, Amro, Sibai
Oral Concurrent Session 2:30 – 2:45 PM Aurora Ballroom B, Lobby Level:
- Postpartum Diuretics for Hypertensive Disorders of Pregnancy: A Systematic Review and Meta-Analysis
Coauthors: Sibai, Bartal
Saturday, February 1st
Oral Concurrent Session 9:30 – 9:45 AM Aurora Ballroom B, Lobby Level:
- Effect of very preterm delivery on outcomes following in-utero spina bifida repair
Coauthor: KuoJen Tsao, MD
Maternal COVID-19 is associated with increased proliferation of placental cytotrophoblasts
Lanners, Le, Chou, Keuls, Murillo Gonzalez, Findley, Goldstein, Parchem R., Parchem J.
Outcomes associated with prolonged rupture of membranes
Claudia Ibarra, MD, MPH
Intrapartum Cesarean Delivery in Different Phases of Labor and Maternal Morbidity
Yossef Bart, MD
Single-nucleus transcriptomic analysis of placental membranes reveals metabolic dysregulation and increased trophoblast proliferation in COVID-19
Le, Lanners, Keuls, Findley, Parchem R., Parchem J.
Fetal Heart Rate Tracings and Adverse Outcomes Among Term Small- versus Appropriate for Gestational Age
Natalie Neff, MD
Maternal anemia and fetal heart rate tracing abnormalities in labor: associated neonatal and maternal outcomes
Aaron Roberts, MD
Maternal COVID-19 and placental expression of senescence-associated secretory phenotype genes
Balhotra, Le, Keuls, Lanners, Findley, Parchem R., Parchem J.
Risk factors for maternal abruption after the fetoscopic laser surgery for Twin Twin transfusion syndrome
Agarwal, Papanna, Lai, Johnson, Backley, Bergh, Hernandez-Andrade, Vilchez, Lemoine, Garcia, Clarete, Garcia, Salazar, Espinoza
Mentor: Espinoza
Diagnosis of vasa previa: Is it time to sweep?
Backley, Bergh, Soto, Agarwal, Lemoine, Johnson, Espinoza, Hernandez-Andrade, Salazar, Papanna
Mentor: Papanna
Evaluation Of Severity Determination Using Transvaginal Ultrasound In Placenta Accreta Spectrum Scoring (TUPAS)
Agarwal, Mehl, Hernandez-Andrade, Lai, Vilchez, Soto, Amro, Guerra, Zhu, Sibai, Blackwell, Papanna
Mentor: Papanna
Suboptimal Fetal Lung Growth After Fetal Endoluminal Tracheal Occlusion in Congenital Diaphragmatic Hernia: Clinical Characteristics
Pacora, Austin, Backley, Bergh, Ebanks, Espinoza, Harting, Hernandez-Andrade, Hughes, Lopez, Papanna, Tsao, Johnson
Mentor: Johnson
Expectant Management versus Prompt Laser Therapy for Stage II Twin-Twin-Transfusion-Syndrome before 18 weeks
Backley, Bergh, Snowise, Johnson, Espinoza, Juckel, Salazar, Papanna, Brock
Mentor: Brock
Changes in Uterine, Placental metrics, and Vascularization in Placenta Left In Situ for PAS management
Barouyr Ajemian, MD
Maternal Outcomes Associated with Antepartum versus Postpartum Eclampsia
Yossef Bart, MD
Do Maternal Outcomes Differ by Specific Blood Pressure Parameters
Yossef Bart, MD
Maternal COVID-19 and placental expression of senescence-associated secretory phenotype genes
Kimen Balhotra, MD
Opt-out and rapid syphilis testing in pregnant patients presenting to the ED: A pre-post Study
Joe Haydamous, MD
The Use of a Novel Point-Of-Care (POC) IgM Test for the Diagnosis of Congenital Syphilis
Irene Stafford, MS, MD
Comparison of Weight Gain versus BMI During Pregnancy on Perinatal Outcomes in Singleton Term Pregnancies
Devangi Mahtani, MD
Change in BMI Category: Impact on Maternal and Neonatal Outcomes
Eleanor Germano, MD
Postpartum Gastroenterology Referrals and Follow Up in Pregnant Patients with Viral Hepatitis
Anthony Chartier, MD
ASPREO secondary analysis
Farah Amro, MD
Keep transfusing until the bleeding stops” – massive transfusion and circulatory overload in obstetric hemorrhage
Aaron Roberts, MD
Opt-out and rapid syphilis testing in pregnant patients presenting to the ED: A pre-post study
Haydamous, Davie, Noriega Valdez, Igbe, Blackwell A., Bakunas, Klausner, Mena, Stafford
Incidence of Placenta Accreta Spectrum in Pregnancies with Placenta Previa and Prior Dilation and Curettage
Sarah Beth Mehl, MD
Female versus Male Fetuses—Variation in Fetal Heart Rate Tracing and Adverse Outcomes at Term
Shareen Patel, MD
Cost Analysis of Permissive Intrapartum Glucose Control for Diabetes: the PERMIT Randomized Controlled Trial
Bitar, Avritscher, Folh, Nazeer, Blackwell, Sibai, Bartal
Continuous Glucose Monitoring Profile Metrics in Pregnancies With and Without Adverse Neonatal Outcomes
Nazeer, Santos, Pedroza, Cornthwaite, Blackwell, Chauhan, Bitar, Sibai, Bartal
Elevated middle cerebral artery peak systolic velocity and donor twin demise in twin-twin transfusion syndrome
Espinoza, Papanna, Johnson, Bergh, Vilchez, Hernandez-Andrade, Backley, Lemoine, Zhu, Llanes, Chmait
Risk Factors for Delivery Less Than 34 Weeks’ Gestation Following Fetoscopic Spina Bifida Repair
Lemoine, Agarwal, Backley, Garcia, Conaway, Salazar, Mann, Zhu, Fletcher, Tsao, Austin, Bergh, Espinoza, Johnson, Refuerzo, Lopez, Sandberg, Lai, Papanna
Mentor: Papanna
Perioperative Risk Factors for Amniotic Band Sequence Following Fetoscopic Laser Photocoagulation for Twin-Twin Transfusion Syndrome
Lemoine, Backley, Espinoza, Johnson, Papanna, Bergh
Mentor: Bergh
Risk Factors for PPROM Following Laser Surgery in Twin-to-Twin Transfusion Syndrome
Backley, Bergh, Lemoine, Agarwal, Salazar, Hernandez-Andrade, Johnson, Papanna, Espinoza
Mentor: Espinoza
Twin Twin Transfusion Syndrome (TTTS) Stage 1: Do we manage expectantly vs. treat immediately?
Backley, Bergh, Espinoza, Lemoine, Agarwal, Vilchez, Pacora, Johnson, Hernandez-Andrade, Salazar, Zhu, Papanna
Mentor: Papanna
MEWS Due to Severe Hypertension Prior to Delivery: Clinical Characteristics and Outcomes
Kristen Cagino, MD
Improving Understanding of Macrosomia With Graphics-Based Educational Tool: A Randomized Clinical Trial (MATE)
Kristen Cagino, MD
Betamethasone for Preterm Premature Rupture of Membranes at Late Prematurity
Yossef Bart, MD
Prevalence of Undiagnosed Placenta Accreta Spectrum after Unplanned Postpartum Hysterectomy
Sarah Beth Mehl, MD
Association of Features of Fetal Heart Rate Tracings and Adverse Neonatal Outcomes at Term
Rachel Wiley, MD
Mediastinal Shift Angle and its association with perinatal mortality and lung volumes in CDH fetuses
Hernandez- Andrade, Gerulewicz Vannini, Hughes, Backley, Refuerzo, Espinoza, Bergh, Pacora Portella, Vilchez, Papanna, Johnson
Association of Fetal Heart Rate Tracing with Neonatal Adverse Outcomes at 32.0 to 36.6 weeks
Christina Cortes, MD